The underlying reason for this unique correlation between MOF, PHF20 levels, and NSCLC progression is unknown, but it will be important to determine, as NSCLCs account for around 85% of lung cancers and are typically resistant to chemotherapy. Here, PHF20 is linked to non-small cell lung carcinoma.